Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Neil D. Gross, Julie E. Bauman, William E. Gooding, William Denq, Sufi M. Thomas, Lin Wang, Simion Chiosea, Brian L. Hood, Melanie Flint, Mai Sun, Thomas P. Conrads, Robert L. Ferris, Jonas T. Johnson, Kim Seungwon, Athanassios Argiris, Lori Wirth, Marina N. Nikiforova, Siegfried Jill M., Grandis Jennifer R.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)3289-3298
Number of pages10
JournalClinical Cancer Research
Issue number12
Publication statusPublished - 11 Apr 2014

Cite this